secwatch.observer — SEC 8-K summary
======================================

Issuer:     LivaNova PLC (LIVN)
CIK:        0001639691
Form:       8-K
Filed at:   2022-09-15T23:59:59+00:00
Accession:  0001639691-22-000088
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LivaNova appoints Brooke Story to Board of Directors effective Sept 15, 2022
----------------------------------------------------------------------------

- Brooke Story appointed to LivaNova Board, brings over 20 years in medtech; currently Worldwide President at BD.
- Story previously held leadership roles at Medtronic, including President of Pelvic Health and Gastric Therapies.
- She will receive a prorated annual board retainer of $110,000, NG committee fee of $8,000, and $130,000 RSU grant.
- No arrangement or related-party transactions exist between Story and LivaNova.
- Story fills a board vacancy; compensation consistent with company's Remuneration Policy for non-employee directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1639691/000163969122000088/0001639691-22-000088-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1639691/000163969122000088/livn-20220915.htm
  HTML page:      https://secwatch.observer/filing/0001639691-22-000088

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer